Prostate Health Index (Phi) and Prostate Cancer Antigen 3 (PCA3) significantly improve prostate cancer detection at initial biopsy in a total PSA range of 2-10 ng/ml. PLoS one 2013; 8(7): e67687.Ferro, M.; Bruzzese, D.; Perdona, S.; Marino, A.; Mazzarella, C.; Perruolo, G.; ...
Interpreting Your Phi Test Results Your Prostate Health Index test results will provide you with scores ranked as within range or out of range for the three tests that make up the phi score. These tests are: PSA: PSA (prostate specific antigen) is a protein that is produced by prostate cel...
Prostate-specific antigen (PSA) and prostate health index (PHI) have been used as biomarkers for prostate cancer detection. In this study, we aimed to evaluate the cost-effectiveness of PHI for prostate cancer detection in Chinese men. Method We developed a Markov model for Chinese male patient...
To explore the utility of Prostate Health Index (PHI) density for the detection of clinically significant prostate cancer (PCa) in a contemporary cohort of men presenting for diagnostic evaluation of PCa.The study cohort included patients with elevated prostate-specific antigen (PSA; >2 ng/mL) an...
Objectives: To determine the efficiency of prostate health index (PHI) calculated simultaneously during an ultrasound‐guided fine‐needle prostate biopsy in prostate cancer diagnosis. Methods: The present study included 258 subsequent patients who underwent a TRUS‐guided biopsy in our ...
JayWhiteBVittalShenoyRonaldFTutroneLawrenceINatureProstate Cancer & Prostatic DiseasesWhite J, Shenoy BV, Tutrone RF, Karsh LI, Saltzstein DR, Harmon WJ, et al. Clinical utility of the Prostate Health Index (phi) for biopsy decision management in a large group urology practice setting. Prostate...
OBJECTIVE: To prospectively evaluate the acute and short-term effects of radical retropubic prostatectomy (RRP) on health-related quality of life (HRQoL) u... E Kouba,JS Hubbard,D Moore,... - 《Bju International》 被引量: 121发表: 2010年 Five year expanded prostate cancer index composite-...
Evaluation of the prostate health index (PHI) as a novel biomarker in active surveillance of prostate cancer. Evaluation of the prostate health index (PHI) as a novel biomarker in active surveillance of prostate cancer.AnimalsHumansRatsCells, Cultured... A Eichholz,F Mccarthy,N Dennis,... - ...
The Beckman Coulter Prostate Health Index (phi) Increases the Specificity of Detection of Prostate Cancer and Reduces the Number of Negative Biopsies J-S Blanchet and X Durand and A. Houlgatte and J.N. Ramirez and K. Bensalah and B. Guille and S. Vincendeau - 《Journal of Mens Health》...
Prostate health index (PHI) The PHI test is a serum-based analysis, developed by Beckman Coulter Inc. and the National Cancer Institute-Early Detection Research Network. The biomarkers included in the PHI are [-2] proPSA, free PSA (fPSA), and total PSA (tPSA). These individual values are...